Literature DB >> 7516930

Interaction of interleukin-1 and interferon-gamma on fibroblast growth factor-induced angiogenesis.

K Norioka1, T Mitaka, Y Mochizuki, M Hara, M Kawagoe, H Nakamura.   

Abstract

The interaction of interleukin-1 (IL-1) and interferon-gamma (IFN-gamma) actions on several aspects of angiogenesis in vitro and in vivo was studied. The proliferation and migration of human umbilical vein endothelial cells cultured with basic fibroblast growth factor (bFGF) were synergistically inhibited by cotreatment with IL-1 and IFN-gamma. Endothelial cell adhesion to collagen was suppressed by IL-1 and the effect was slightly enhanced by the combination of IL-1 and IFN-gamma. Local administration of IL-1 (10,000 U) and IFN-gamma (1,000 U) inhibited bFGF-induced angiogenesis in the skin of mice, and synergistic inhibitory activity of the combination was demonstrated. Expression of FGF receptors was strongly downregulated by the combination, whereas expressions of epidermal growth factor (EGF) receptors, integrin beta 1 and integrin beta 3 were not. EGF partially abrogated the growth-inhibitory effects of IL-1 and IFN-gamma. These findings indicate that IL-1 and IFN-gamma are each able to act an angiogenesis inhibitor in a situation where FGF plays a major role in angiogenesis, and the activity is synergistically enhanced when they are used in combination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516930      PMCID: PMC5919500          DOI: 10.1111/j.1349-7006.1994.tb02390.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  32 in total

Review 1.  Tumor interactions with the vasculature: angiogenesis and tumor metastasis.

Authors:  C H Blood; B R Zetter
Journal:  Biochim Biophys Acta       Date:  1990-06-01

2.  Acute and chronic inflammatory responses to local administration of recombinant IL-1 alpha, IL-beta, TNF alpha, IL-2 and Ifn gamma in mice.

Authors:  C J Dunn; M M Hardee; N D Staite
Journal:  Agents Actions       Date:  1989-06

3.  Interleukin 1 is an autocrine regulator of human endothelial cell growth.

Authors:  F Cozzolino; M Torcia; D Aldinucci; M Ziche; F Almerigogna; D Bani; D M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  In vivo angiogenic activity of interleukins.

Authors:  D BenEzra; I Hemo; G Maftzir
Journal:  Arch Ophthalmol       Date:  1990-04

5.  Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.

Authors:  J Kandel; E Bossy-Wetzel; F Radvanyi; M Klagsbrun; J Folkman; D Hanahan
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

6.  Inhibition of in vitro angiogenesis by lymphotoxin and interferon-gamma.

Authors:  N Tsuruoka; M Sugiyama; Y Tawaragi; M Tsujimoto; T Nishihara; T Goto; N Sato
Journal:  Biochem Biophys Res Commun       Date:  1988-08-30       Impact factor: 3.575

7.  Dual role of tumor necrosis factor-alpha in angiogenesis.

Authors:  L F Fajardo; H H Kwan; J Kowalski; S D Prionas; A C Allison
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

8.  Human endothelial cell cultures: phenotypic modulation by leukocyte interleukins.

Authors:  R Montesano; L Orci; P Vassalli
Journal:  J Cell Physiol       Date:  1985-03       Impact factor: 6.384

9.  Inhibition of endothelial cell proliferation by gamma-interferon.

Authors:  R Friesel; A Komoriya; T Maciag
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

10.  Platelet-derived growth factor in chemotactic for fibroblasts.

Authors:  H Seppä; G Grotendorst; S Seppä; E Schiffmann; G R Martin
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  4 in total

Review 1.  Interferons as antiangiogenic agents.

Authors:  Daniel J Lindner
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

2.  The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines.

Authors:  E Guenzi; K Töpolt; E Cornali; C Lubeseder-Martellato; A Jörg; K Matzen; C Zietz; E Kremmer; F Nappi; M Schwemmle; C Hohenadl; G Barillari; E Tschachler; P Monini; B Ensoli; M Stürzl
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 3.  The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

Authors:  O V Volpert; V Stellmach; N Bouck
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

Review 4.  Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

Authors:  Marco Rusnati; Chiara Urbinati; Silvia Bonifacio; Marco Presta; Giulia Taraboletti
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.